Amneal Pharmaceuticals, Inc Class A Common Stock
Price & Volume
Stats
See moreOpen | $8.80 |
Previous Close | $8.73 |
Day Range | $8.66-$8.80 |
52W Range | $5.01-$9.47 |
Market Cap | $4B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $2.6B |
Revenue Growth (YoY) | 13.3% |
Gross Profit (12 Mos) | $979M |
Diluted EPS | -$0.86 |
News
See moreYahoo Finance • 4 months ago
Amneal to Report Third Quarter 2024 Results on November 8, 2024
Yahoo Finance • 4 months ago
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
Yahoo Finance • 6 months ago
Amneal Reports Second Quarter 2024 Financial Results
About
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 7,850 |
